Agnieszka Hobbs

Apr 18, 2024 | biorxiv.org | Giulia Dowgier |Agnieszka Hobbs |David A. Greenwood |Marianne Jane Shawe-Taylor

AbstractEmerging SARS-CoV-2 variants require rapid assessments of pathogenicity and evasion of existing immunity to inform policy. A crucial component of these assessments is accurate estimation of serum neutralising antibody titres using cultured live virus isolates.

Mar 11, 2024 | thelancet.com | Marianne Jane Shawe-Taylor |David A. Greenwood |Agnieszka Hobbs |Giulia Dowgier

On Dec 13, 2023, WHO's Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) reiterated their guidance1WHOStatement on the antigen composition of COVID-19 vaccines. from May, 2023, recommending updating vaccines to better induce neutralising antibodies against the omicron XBB.1 lineage and its descendants that were in circulation at the time.